Cross Country Healthcare (CCRN) Cost of Revenue (2010 - 2026)

Cross Country Healthcare has reported Cost of Revenue for 17 years, with the latest figure at $193.5 million in Q1 2026.

• For the quarter ending Q1 2026, Cost of Revenue fell 17.59% year-over-year to $193.5 million; the trailing twelve-month figure through Mar 2026 stood at $799.4 million (down 20.27% YoY), and the FY2025 full-year result was $840.7 million, down 21.41% from the prior year.
• Cost of Revenue for Q1 2026 stood at $193.5 million, up from $188.8 million in the prior quarter.
• The five-year high for Cost of Revenue was $613.9 million in Q1 2022, with the low at $188.8 million in Q4 2025.
• Historically, Cost of Revenue has averaged $344.2 million across 5 years, with a median of $301.9 million in 2024.
• Annual changes were most pronounced in 2022 — Cost of Revenue surged 138.17% — and 2024, when it tumbled 37.54%.
• Cross Country Healthcare's Cost of Revenue stood at $489.3 million in 2022, then tumbled by 33.87% to $323.5 million in 2023, then decreased by 23.37% to $247.9 million in 2024, then dropped by 23.86% to $188.8 million in 2025, then advanced by 2.48% to $193.5 million in 2026.
• The last three Cost of Revenue figures came in at $193.5 million (Q1 2026), $188.8 million (Q4 2025), and $199.1 million (Q3 2025), per Business Quant data.